Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-01-04
2005-01-04
Swartz, Rodney P (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S085100, C424S093200, C424S185100, C530S350000, C530S389500, C530S412000, C536S022100, C536S023100, C536S023700
Reexamination Certificate
active
06838085
ABSTRACT:
Nucleic acid, including DNA, for immunization to generate a protective immune response in a host, including humans, to a major outer membrane protein of a strain ofChlamydia, preferably contains a nucleotide sequence encoding a MOMP or a MOMP fragment that generates antibodies that specifically react with MOMP and a promoter sequence operatively coupled to the first nucleotide sequence for expression of the MOMP in the host. The non-replicating vector may be formulated with a pharmaceutically-acceptable carrier for in vivo administration to the host.
REFERENCES:
patent: 5589466 (1996-12-01), Felgner et al.
patent: 6235290 (2001-05-01), Brunham
patent: 6344202 (2002-02-01), Brunham
patent: 0 192033 (1986-08-01), None
patent: WO 9802546 (1998-01-01), None
Donnelly et a., Protective Efficacy of Intramuscular Immunization with Naked DNA Ann. N.Y. Acad. Sci. 772 (1995) pp. 40-46 XP 000576178.
D. M. Pardoll and A. M. Beckerieg, Exposing the Immunology of Naked DNA Vaccines. Immunity 3, pp. 165-169 (1995).
W.M. McDonnell and F. K. Askari, Molecular Medicine DNA Vaccine. N. Engl. J. Med. 334, pp. 42-45 (1996).
J. B. Ulmer et al., Heterologous Protection Against Influenza by injection of DNA Encoding a Viral Protein. Science vol. 259, pp. 1745-1749 (1993).
B. Wang et al., Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad.. Sci. vol. 90, pp. 4156-4160 (1993).
G. J. M. Cox, T.J. Zamb, L.A. Babiuk, Bovine herpesvirus 1: Immune Responses in Mice and Cattle Injected with Plasmid DNA. J. Virol. vol. 67, pp. 5664-5667(1993).
E. Raz et al., Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl.Acad. Sci. vol. 91, pp. 9519-9523(1994).
Z. Q. Xiang et al., Vaccination with a Plasmid Vector Carrying the Rabies Virus Glycoprotein Gene Induces Protective immunity against Rabies Virus. Virology vol. 199, pp. 132-140 (1994).
J.J.Donnelly et al., Protection against Papillomavirus with a Polynucleotide Vaccine. J. Infect. Dis. vol. 713, pp. 314-320 (1996).
D. L. Montgomery et al., Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors. Cell. Biol. vol. 12, pp. 777-783 (1993).
J.J. Donnelly et al., Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus. Nature Medicine vol. 1, pp. 583-587 (1995).
G. H. Rhodes et al., Characterization of Humoral Immunity after DNA Injection. Dev. Biol. Stand. vol. 82, pp. 229-236 (19994).
H. L. Davis, M. L Michel, R. G. Whalen, DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Human Mol. Genetics. vol. 2, pp. 1847-1851 (1993).
J. B. Ulmer et al., Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine vol. 12, pp. 1541-1544 (1994).
Z. Xiang and H. C. J. Ertl. Manipulation of the Immune Response to a Plasmid-Encoded Viral Antigen by Coinoculation with Plasmids Expressing Cytokines. Immunity vol. 2, pp. 129-135 (1995).
E. F. Fynan et al, DNA vaccines: Protective immunizations by parenteral, mucosal, and gen-gun inoculations. Proc. Natl. Acad. Sci. vol. 90, pp. 11478-11482 (1993).
E. Manickan, R. J. D. Rouse, Z. Yu, J. Genetic Immunization Against Herpes Simplez Virus. J. Immunol. vol. 155, pp. 259-265 (1995).
M. Sedegah, R. Hedstorm, P. Hobart, S. L. Hoffman, Protection against malaria by immunization with plasmid. DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. vol. 91, pp. 9866-9870 (1994).
M.A. Barry, W.C. Lai, S.A. Johnston, Protection against mycoplasma infection using expression library immunization. Nature vol. 377, pp. 632-635 (1995).
D. Xu and F. Y. Liew, Genetic vaccination against leishmaniasis. Vaccine vol. 12, pp. 1534-1536 (1994).
D. B. Lowrie, R.E. Tascon, M. J. Colston, Towards a DNA vaccine against tuberculosis. Vaccine vol. 12, pp. 1537-1540 (1994).
J. W. Moulder, Interaction ofchlamydiaand Host Cells in Vitro. Microbiol. Rev. vol. 55, pp. 143-190 (1991).
J. Schachter, The Intracellular Life ofChlamyida.Curr. Top. Microbiol. Immunol, vol. 138, pp. 109-139 (1988).
S. D. Hillis and J. N. Wasserheit, Screening forchlamydia_A key to the prevention of pelvic inflammatory disease. N. Engl. J. Med. vol. 334, pp. 399-1401 (1996).
R. C. Brunham and R. W. Peeling,Chlamydia trachomatisantigens: Role in Immunity and Pathogenesis. Infectious Agents and Disease vol. 3, pp. 218-233 (1994).
R. P. Morrison, D.S. Manning, H. D. Caldwell, Immunology ofChlamydia trachomatisinfections:Immunoprotective and immunopathogenetic responses. Advances in Host Defence Mechanisms, T.C. Quinn, Ed. (Raven Press, New York, 1992), pp 52-84.
T. Grayston and S-P. Wang, The potential for Vaccine against Infection of the Genital tract withChlamydia trachomatis.Sex Trans. Dis. vol. 5, pp. 73-77 (1978).
J.T. Grayston and S-P Wang, New knowledge ofchlamydiaand the diseases the cause. J. Infect.Dis. vol. 132, pp. 87-105 (1975).
H. R. Taylor, J. Whittum-Hudson, J. Schachter, et al. Oral immunization withchlamydiamajor outer member protein (MOMP) Invest. Ophthalmol. Vis. Sci. vol. 29, pp. 1847-1853 (1988).
B.E. Batteiger, R. G. Rank, P.M. Bavoil, et al., Partial protection against genital reinfection by immunization of guinea-pigs with isolated . . . J. Gen. Microbiol. vol. 139, pp. 2965-2972 (1993).
M. Campos et al., Achlamydiamajor uter membrane protein extract as a trachoma vaccine candidate. Invest. Ophthalmol. Vis. Sci. vol. 36, pp. 1477-1491 (1995).
H. Su, M. Parne, H. D. Caldwell, Protective efficacy of a parenterally administedred MOMP-derived synthetic olygopeptide . . . Vaccine vol. 13, pp. 1023-1032 (1995).
T.-W. Tan, A.J. Herring, I. E. Protection of sheep againstChlamydia psittaciinfection with a subcellular vaccine . . . Anderson, Infect. Immun. vol. 58, pp. 3101-3108 (1990).
M. Tuffrey, F. Alexander, W. Conlan, Heterotypic protection of mice againstChlamyida salpingitisand colonization of the lower genital tract with a human . . . J. Gen. Microbiol. vol. 138, pp. 1707-1715 (1992).
Y. -X. Zhang, J. G. Fox, Y. Ho, Comparison of the major Outer-Membrane protein (MOMP) gene of mouse Pneumonitis. (MoPn) and . . . Mol. Biol. Evol. vol. 10, pp. 1327-1342 (1993).
R. P. Morrison, K. Feilzer, D. B. Tumas, Gene Knockout mice establish a primary protective role for major histocompatibility . . . , Infect. Immun. vol. 63, pp. 4661-4668 (1995).
H. Su and H. D. Caldwell, CD4=T Cells play a significant role in adoptive immunity toChlamydia trachomatisinfection of the mouse genital tract. Infect. Immun. vol. 63, pp. 3302-3308 (1995).
J. U. Igietseme et al., Resolution of MurineChlamydialGenital infection by the adoptive transfer of a Biova-Specific, TH1Lymphocytecione. Reg.Immunol. vol. 5, pp. 317-324 (1993).
J. U. Igietseme and R. G. Rank, Susceptibility to reifection after a primarychlamydialgenital infection is associated with a decrease of . . . , Infect. Immun. vol. 59, pp. 1346-1351 (1991).
D. M. Williams, J. Schachter, J.J. Coalson, Cellular Immunity to the Mouse Pneumonitis Agent. J. Infect. Dis. vol. 149, pp. 630-639 (1984).
41. G. Tipples and G. McClarty, Cloning and Expression of theChlamyida trachomatisGene for CTP Synthetase. J. Biol. Chem. vol. 270, pp. 7908-7914 (1995).
X. Yang, K. T. HayGlass, R.C. Brunham, Genetically Determined Differences in IL-10 and IFN Response correlate with Clearence . . . , J. Immunol., vol. 156, pp. 4338-4344 (1996).
H. Su and H. D. Caldwell, Kinetics ofChlamyidaantigen processing and presentation to T Cells by Paraformaldehyde-Fixed Murine Bone Marrow-Derived Macrophages. Infect. Immun. vol. 63, pp. 946-953 (1995).
A. S. McWilliam, D. Nelson, J.A. Thomas, Rapid dendritic cell recruitment is a Hallmard of the acute inflammatory response at mucosal surfaces. J. Exp. Med. vol. 179, pp. 1331-1336 (1994).
M. R. Neutra, E. Pringault, J.-P. Kraehenbuhl, Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu. Rev. Immunol. vol. 14, pp. 275-300 (1996).
J.M. Austyn, New
Sim & McBurney
Swartz Rodney P
University of Manitoba
LandOfFree
DNA immunization against Chlamydia infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA immunization against Chlamydia infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA immunization against Chlamydia infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3437013